| Literature DB >> 35462559 |
Ki-Ryeong Kim1, Eun-Jung Cho1, Jae-Won Eom1, Sang-Seok Oh1, Tomohiro Nakamura2, Chang-Ki Oh2, Stuart A Lipton3,4, Yang-Hee Kim5.
Abstract
Protein S-nitrosylation is known to regulate enzymatic function. Here, we report that nitric oxide (NO)-related species can contribute to Alzheimer's disease (AD) by S-nitrosylating the lysosomal protease cathepsin B (forming SNO-CTSB), thereby inhibiting CTSB activity. This posttranslational modification inhibited autophagic flux, increased autolysosomal vesicles, and led to accumulation of protein aggregates. CA-074Me, a CTSB chemical inhibitor, also inhibited autophagic flux and resulted in accumulation of protein aggregates similar to the effect of SNO-CTSB. Inhibition of CTSB activity also induced caspase-dependent neuronal apoptosis in mouse cerebrocortical cultures. To examine which cysteine residue(s) in CTSB are S-nitrosylated, we mutated candidate cysteines and found that three cysteines were susceptible to S-nitrosylation. Finally, we observed an increase in SNO-CTSB in both 5XFAD transgenic mouse and flash-frozen postmortem human AD brains. These results suggest that S-nitrosylation of CTSB inhibits enzymatic activity, blocks autophagic flux, and thus contributes to AD pathogenesis.Entities:
Year: 2022 PMID: 35462559 DOI: 10.1038/s41418-022-01004-0
Source DB: PubMed Journal: Cell Death Differ ISSN: 1350-9047 Impact factor: 12.067